To hear about similar clinical trials, please enter your email below
Trial Title:
Predictive Factors for Survival in Aggressive Meningiomas
NCT ID:
NCT05793034
Condition:
Meningioma
Meningioma Atypical
Anaplastic Meningioma
Conditions: Official terms:
Meningioma
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Diagnostic
Masking:
None (Open Label)
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
Biological biomarker assessment
Description:
IHC, PCR, NGS, methylome
Arm group label:
Biological biomarker assessment
Summary:
The investigators plan to collect clinical and molecular data, including ICH, PCR, NGS
and methylome, from patients operated on for grade 2 or grade 3 meningioma. The purpose
of the study is to identify reliable and easy-to-assess predictive factors for recurrence
and survival after surgery.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. Patient operated for atypical (grade 2) meningioma; or
2. Patient operated for anaplastic (grade 3) meningioma;
3. Timeframe for surgery, 1999-2019
Exclusion criteria
1) Patient lost at follow-up
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Fondazione Policlinico Universitario A. Gemelli IRCCS
Address:
City:
Rome
Zip:
00168
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Alessandro Olivi, MD
Phone:
+39 06 3015 4120
Email:
alessandro.olivi@policlinicogemelli.it
Contact backup:
Last name:
Roberto Pallini, MD, PhD
Phone:
+39 06 3015 5414
Email:
roberto.pallini@unicatt.it
Investigator:
Last name:
Rina Di Bonaventura, MD
Email:
Sub-Investigator
Investigator:
Last name:
Q. Giorgio D'Alessandris, MD
Email:
Sub-Investigator
Start date:
January 7, 2021
Completion date:
December 31, 2023
Lead sponsor:
Agency:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Agency class:
Other
Source:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05793034
